- Coronary Stents Coronary Balloons Catheters Guide Wires Introducer Sheaths Accessories Peripheral Interventional Products
- Immunoassay Molecular Diagnostics Hematology Diagnostics POCT Lab Solution
- Structural Heart Diseases Products
- Vascular Access Blood Pressure Transducer Arterial Blood Sampler CVC Accessories IV Catheter Needle-free Connectors Insulin Injection Pain Relief
- Hemodialysis consumables Hemoperfusion Cartridge Dialysis machine
- ECG Patient Monitor Oximeter
- Cardiovasculars Oncology Anti-infectives Central Nervous System Others
- Endoscope Endoscopic Ultrasound System
- Trauma Implant Spinal Implant Artificial Joint Sports Medicine
- Pacemakers and Leads Equipments
- Metabolic Diseases Cardiovascular Diseases
- ELISA CLIA FIA
- Nucleic Acid Extraction Nucleic Acid Extraction ＆ PCR Kits Real-Time PCR
- Thrombelastography Analyzer Blood Grouping Platelet Aggregation
- POCT - FIA Colloidal Gold
- NeoECG Holter Monitor Portable ECG Monitor AI-ECG Pocket ECG
- Patient Monitor Vital Signs Monitor End-tidal Capnography
- Fingertip Oximeter Handheld Oximeter Wrist Oximeter Wearable Oximeter All-in-One Health Monitor POCT Solution
- OBS Locking Compression Plate Locking Plates Conventional Plates Mini Plates System Screws Patella Ring - Patented Product Metal Pins Cable System
- Internal Fixation System Laminoplasty Plate System Percutaneous Kyphoplasty Fusion Cage Cervical Fixation System
- Hip System Knee System
- Suture Anchor Suture Button
Clinical Trials
View onClinicalTrials.gov
Development Highlights
1. Dual-Target Mechanism:
A single GalNAc-siRNA designed to simultaneously silence PCSK9 and ANGPTL3, addressing complementary pathways in LDL-C and triglyceride-rich lipoprotein metabolism.
2. First-in-Class Development:
MWX205 is the world’s first PCSK9/ANGPTL3 dual-target siRNA to enter clinical development, with a Phase 1 clinical program underway.
3. Potential for Comprehensive Lipid Management:
Designed to address both elevated LDL-C and triglycerides, with the potential to simplify long-term lipid management by integrating two lipid-lowering mechanisms into a single therapeutic.
Thank You for Your Attention on Lepu Medical!
Email us with any questions or inquiries or use our contact data. We would be happy to answer your questions.
